For whom the bell tolls: isoniazid preventive therapy and tuberculosis drug resistance.
Where this comes from
- Record sourced from PubMed, PMID 23576813.
- Also identified by DOI 10.1126/scitranslmed.3006094.
- No licence information is recorded for this record.
- Because redistribution is not established, this page shows the abstract only. Follow the links below for the full text.
Abstract
The expected increase in drug-resistant tuberculosis due to large-scale preventive treatment in people living with HIV calls for reconsidering the "double use" of isoniazid for prophylaxis and curative treatment (Mills et al., this issue).
Medical subject headings
- Antitubercular Agents
- Isoniazid
- Tuberculosis